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Abstract
Module network inference is an established statistical method to reconstruct co-expression
modules and their upstream regulatory programs from integrated multi-omics datasets mea-
suring the activity levels of various cellular components across different individuals, experi-
mental conditions or time points of a dynamic process. We have developed Lemon-Tree,
an open-source, platform-independent, modular, extensible software package implement-
ing state-of-the-art ensemble methods for module network inference. We benchmarked
Lemon-Tree using large-scale tumor datasets and showed that Lemon-Tree algorithms
compare favorably with state-of-the-art module network inference software. We also ana-
lyzed a large dataset of somatic copy-number alterations and gene expression levels mea-
sured in glioblastoma samples from The Cancer Genome Atlas and found that Lemon-Tree
correctly identifies known glioblastoma oncogenes and tumor suppressors as master regu-
lators in the inferred module network. Novel candidate driver genes predicted by Lemon-
Tree were validated using tumor pathway and survival analyses. Lemon-Tree is available
from http://lemon-tree.googlecode.com under the GNU General Public License version 2.0.
Introduction
Recent years have witnessed a dramatic increase in new technologies for interrogating the ac-
tivity levels of various cellular components on a genome-wide scale, including genomic, epige-
nomic, transcriptomic, and proteomic information [1]. It is generally acknowledged that
integrating these heterogeneous datasets will provide more biological insights than performing
separate analyses. For instance, in 2005, Garraway and colleagues combined SNP-based genetic
maps and expression data to identify a novel transcription factor involved in melanoma pro-
gression [2]. More recently, international consortia such as The Cancer Genome Atlas (TCGA)
or the International Cancer Genome Consortium (ICGC) have launched large-scale initiatives
to characterize multiple types of cancer at different levels (genomic, transcriptomic, epige-
nomic, etc.) on several hundreds of samples. These integrative studies have already led to the
identification of novel cancer genes [3, 4].
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Among the many ways to approach the challenge of data integration, module network infer-
ence is a statistically well-grounded method which uses probabilistic graphical models to re-
construct modules of co-regulated genes (or other biomolecular entities) and their upstream
regulatory programs and which has been proven useful in many biological case studies [5, 6].
The module network model was introduced as a method to infer regulatory networks from
large-scale gene expression compendia [5] and has subsequently been extended to integrate
eQTL data [7, 8], regulatory prior data [9], microRNA expression data [10], clinical data [11],
copy number variation data [12] or protein interaction networks [13]. The original module
network learning algorithm depended on a greedy heuristic, but subsequent work has extended
this with alternative heuristics [14], Gibbs sampling [15] and ensemble methods [16]. Module
network inference can be combined with gene-based network reconstruction methods [17, 18]
and recently a method has been developed to reconstruct module networks across multiple
species simultaneously [19]. This methodological and algorithmic work has complemented
studies that were solely focused on applying module network methods to provide new biologi-
cal and biomedical insights [20–27].
Although the success of the module network method is indisputable, the various methodo-
logical innovations have been made available in a bewildering array of tools, written in a variety
of programming languages, and, when source code has been released, it has never been with an
OSI compliant license (Table 1). Here we present Lemon-Tree, a ‘one-stop shop’ software suite
for module network inference based on previously validated algorithms where a community of
developers and users can implement, test and use various methods and techniques. We bench-
marked Lemon-Tree using large-scale datasets of somatic copy-number alterations and gene
expression levels measured in glioblastoma samples from The Cancer Genome Atlas and
found that Lemon-Tree compares favorably with existing module network softwares and cor-
rectly identifies known glioblastoma oncogenes and tumor suppressors as master regulators in
the inferred module network. Novel candidate driver genes predicted by Lemon-Tree were val-
idated using pathway enrichment and survival analysis.
Table 1. Survey of module networks software tools, in chronological order by their ﬁrst release date.
Software Language I/O Source Data URL Year
Genomica Java g no m http://genomica.weizmann.ac.il 2003
Geronemo Java g no m, e http://ai.stanford.edu/~koller/index.html 2006
Lemone Java/Matlab c yes1 m, mi http://bioinformatics.psb.ugent.be/software/details/Lemone 2007
Lirnet Matlab c yes2 m, e http://homes.cs.washington.edu/~suinlee/lirnet 2009
CONEXIC Java c no m, c http://www.c2b2.columbia.edu/danapeerlab/html/conexic.html 2010
PMN Unix binary c no m, p http://www.compbio.cs.huji.ac.il/PMN 2010
ARBORETUM C c yes2 m-s http://pages.discovery.wisc.edu/~sroy/arboretum 2013
MERLIN C c yes2 m http://pages.discovery.wisc.edu/~sroy/merlin 2013
Lemon-Tree Java c yes3 m, mi, e, c, any http://lemon-tree.googlecode.com 2014
I/O: g, graphical user interface; c, command line. Supported data integration: m, mRNA; mi, microRNA; e, eQTL; c, CNV; p, protein interactions; m-s,
mRNA multiple species; any, any combination of discrete or continuous data types measured on the same samples.
(1) Not OSI compliant.
(2) No license provided.
(3) GPL license.
doi:10.1371/journal.pcbi.1003983.t001
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Design and Implementation
Lemon-Tree is a platform-independent command-line tool written in Java which implements
previously validated algorithms for model-based clustering [15] and module network inference
[16]. The principal design difference between Lemon-Tree and other module network soft-
wares (e.g. Genomica [5] or CONEXIC [12]) consists of the separation of module learning and
regulator assignment. We have previously shown that running a two-way clustering algorithm
until convergence, and thereafter identifying the regulatory programs that give rise to the in-
ferred condition clusterings for each gene module results in higher module network model like-
lihoods and reduced computational cost compared to the traditional approach of iteratively
updating gene modules and regulator assignments [14, 16]. Hence Lemon-Tree is run as a se-
ries of tasks, where each task represents a self-contained step in the module network learning
and evaluation process and the output of one task forms the input of another (a work flow re-
presentation of the different steps is illustrated in Fig. 1):
Fig 1. Flow chart for integrative module network inference with Lemon-Tree. This figure shows the
general workflow for a typical integrative module network inference with Lemon-Tree. Blue boxes indicate the
pre-processing steps that are done using third-party software such as R or user-defined scripts. Green boxes
indicate the core module network inference steps done with the Lemon-Tree software package. Typical post-
processing tasks (orange boxes), such as GO enrichment calculations, can be performed with Lemon-Tree
or other tools. The Lemon-Tree task names are indicated in red (see main text for more details).
doi:10.1371/journal.pcbi.1003983.g001
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Task “ganesh” Run one or more instances of a model-based Gibbs sampler [15] to simulta-
neously infer co-expression modules and condition clusters within each module from a gene
expression data matrix.
Task “tight_clusters” Build consensus modules of genes that systematically cluster together
in an ensemble of multiple “ganesh” runs. Consensus modules are reconstructed by a novel
spectral edge clustering algorithm which identifies densely connected sets of nodes in a weight-
ed graph [28], with edge weight defined here as the frequency with which pairs of genes belong
to the same cluster in individual “ganesh” runs. Details about the tight clustering algorithm are
provided in S1 Text.
Task “regulators” Infer an ensemble of regulatory programs for a set of modules and com-
pute a consensus regulator-to-module score. Regulatory programs take the form of a decision
tree with the (expression level of) regulators at its internal nodes. The regulator score takes into
account the number of trees a regulator is assigned to, with what score (posterior probability),
and at which level of the tree [16]. An empirical distribution of scores of randomly assigned
regulators is provided to assess significance. Regulator data need not come from the same data
that was used for module construction but can be any continuous or discrete data type mea-
sured on the same samples. When multiple regulator types are considered, the “regulators”
task is run once for each of them.
Task “experiments” For a fixed set of gene modules, cluster conditions separately for each
module using a model-based Gibbs sampler [15] and store the resulting hierarchical condition
trees in a structured XML file.
Task “split_reg” Assign regulators to a given range of one or more modules. This task al-
lows parallelization of the “regulators” task and needs the output of the “experiments” task as
an input.
Task “figures” Draw publication-ready visualizations for a set of modules in postscript for-
mat, consisting of a heatmap of genes in each module, organized according to a consensus clus-
tering of the samples, plus heatmaps of its top-scoring regulators, separated according to the
regulator type (cf. S1 Fig.).
Task “go_annotation” Calculate gene ontology enrichment for each module using the
BiNGO [29] library.
While a typical run of Lemon-Tree will apply tasks “ganesh”, “tight_clusters” and “regulators”
in successive order, the software is designed to be flexible. For instance, the “tight_clusters” task
can be equally well applied to build consensus clusters from the output of multiple third-party
clustering algorithms, regulators can be assigned to the output of any clustering algorithm, etc.
To facilitate this interoperability with other tools, input/output is handled via plain text files with
minimal specification, the only exception being the storage of the regulatory decision trees which
uses an XML format. Tasks also permit customization by changing the value of various parame-
ters. We have purposefully provided default values for all parameters, based on our experience
accrued over many years of developing and applying the software to a great variety of datasets
frommultiple organisms, and avoided mentioning any parameter settings in the Tutorial such
that first-time users are presented with a simple workflow. Detailed instructions on how to inte-
grate or extend (parts of) Lemon-Tree and a complete overview of all parameters and their de-
fault values are provided on the project website (http://lemon-tree.googlecode.com/).
Results
Benchmark between Lemon-Tree and CONEXIC
We compared the performance of Lemon-Tree with CONEXIC (COpy Number and Expres-
sion In Cancer), a state-of-the-art module network algorithm designed to integrate matched
Module Network Inference with Lemon-Tree
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copy number (amplifications and deletions) and gene expression data from tumor samples
[12]. The general framework is the same for the algorithms, with modules of co-expressed
genes associated to a list of regulators assigned via a probabilistic score. However, the probabi-
listic techniques used to build the modules and to assign regulators are different. We ran the
two programs on the same large-scale reference data set to evaluate these differences. We used
Gene Ontology (GO) enrichment and a reference network of protein-protein interactions to
compare the co-expressed modules and the regulatory programs.
We downloaded gene expression and copy number glioblastoma datasets from the TCGA
data portal [3] and we built an expression data matrix of 250 samples and 9,367 genes. We lim-
ited the number of samples for this benchmark study in order to save computational time. For
the candidate regulators, we selected the top 1,000 genes that were significantly amplified or de-
leted as input genes for both CONEXIC and Lemon-Tree. To run CONEXIC, we followed the
instructions of the manual and more specifically used the recommended bootstrapping proce-
dure to get robust results. For Lemon-Tree, we generated an ensemble of two-way clustering
solutions that were assembled in one robust solution by node clustering. Then we assigned
the regulators using the same input list as with CONEXIC. A global score was calculated for
each regulator and for each module and we selected the top 1% regulators as the final list
(see S1 Text). The total run-time for the two software programs on the benchmark dataset
was quite similar, with a small advantage for Lemon-Tree (S5 Table).
To compare the Gene Ontology (GO) categories between Lemon-Tree and CONEXIC, we
built a list of all common categories for a given p-value threshold and converted the corrected
p-values to −log10(p-value) scores. We selected the highest score for each GO category and we
counted the number of GO categories having a higher score for Lemon-Tree or CONEXIC, and
calculated the sum of scores for each GO category and each software. The results shown in Fig. 2
indicate that Lemon-Tree clusters have a higher number of GO categories with lower p-values
than CONEXIC (Fig. 2A), and that globally the p-values are lower for Lemon-Tree clusters
(Fig. 2B). To benchmark the regulators’ assignment of each software, we used a scoring scheme
developed by Jornsten et al. [30]. For a given interaction distance in a reference protein-protein
interaction network, we calculated the relative enrichment of known interactions in the networks
inferred by Lemon-Tree and CONEXIC with respect to known interactions in networks where
Fig 2. Comparison between Lemon-Tree and CONEXIC.Gene Ontology (GO) enrichment of the co-expressed gene clusters, indicated by counting the
number of GO categories having a lower p-value (A) and by comparing the sum of the quantity -log10(p-value) (B) for different global p-value cutoff levels (x-
axis). (C) Relative enrichment of inferred interactions by Lemon-Tree and CONEXIC to knownmolecular protein-protein interactions (PPI), for increasing
interaction distances.
doi:10.1371/journal.pcbi.1003983.g002
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edges have been randomly re-assigned (see S1 Text). Fig. 2C shows the relative enrichments for
interaction distances ranging from 1 (direct interaction) to 4. The Lemon-Tree inferred network
is enriched for short or direct paths, a desired characteristic for well-estimated networks [30].
These results are consistent with a previous study conducted on bacteria and yeast data,
where we showed a better performance in terms of enrichment in functional categories and
known regulatory interactions of the algorithms underlying the Lemon-Tree software over
Genomica (a software tool on which CONEXIC is based) [17]. Taken together, these results
show that Lemon-Tree compares favorably with state-of-the-art module network inference
algorithms.
Integrative analysis of TCGA glioblastoma expression and copy-number
data
Lemon-Tree can be used to integrate various types of ‘omics’ data and generate new biological
and biomedical insights. Here, we exemplify how to integrate copy-number and expression
data for a large dataset of glioblastoma tumor samples and show that the results are enriched in
known key players of canonical tumor pathways as well as novel candidates. Malignant gliomas
are the most common subtype of primary brain tumors and are very aggressive, highly invasive
and neurologically destructive. Glioblastoma multiforme (GBM) is the most malignant form of
gliomas, and despite intense investigation of this disease in the past decades, most patients with
GBM die within approximately 15 months of diagnosis [31]. Somatic copy-number alterations
(SCNA) are extremely common in cancer and affect a larger fraction of the genome than any
other types of somatic genetic alterations. They have critical roles in activating oncogenes and
inactivating tumor suppressor genes, and their study has suggested novel potential therapeutic
strategies [32, 33]. However, distinguishing the alterations that drive cancer development from
the passenger SCNAs that are acquired over time during cancer progression is a critical chal-
lenge. Here we use the module network framework implemented in the Lemon-Tree software
tool to build a module network relating genes located in regions that are significantly amplified
or deleted to modules of co-expressed genes. In other words, the module network selects and
prioritizes copy-number altered genes that might play a role (direct or indirect) for clusters of
co-expressed genes, performing important biological functions in glioblastoma. The resulting
module network is used to prioritize SCNA genes that are amplified or deleted, and to provide
novel hypotheses regarding drivers of glioblastoma.
We downloaded data from the TCGA project portal [3] and we selected 484 glioblastoma
tumor samples from different patients (representing 91% of the available samples). We selected
7,574 gene expression profiles and generated an ensemble of two-way clustering solutions that
were assembled in one robust solution by node clustering, resulting in a set of 121 clusters com-
posed of 5,423 genes (S1 Text and S1 Table). We assembled a list of genes amplified and deleted
in glioblastoma tumors from the most recent GISTIC run of the Broad Institute TCGA Copy
Number Portal on glioblastoma samples. GISTIC [34] is the standard software tool used for
the detection of peak regions significantly amplified or deleted in a number of samples from
copy-number profiles. We also included in the list a number of key genes amplified or deleted
from previous studies [34–36]. The final list is composed of 353 amplified and 2,007 deleted
genes (with all genes present on sex chromosomes excluded). We did not use extremely strin-
gent statistical thresholds for the selection, to avoid the exclusion of potentially interesting can-
didates. From this list we built SCNA gene copy-number profiles using TCGA data and used
those profiles as candidate regulators for the co-expressed gene clusters. We assigned regulators
independently for amplified and deleted genes, and we selected the top 1% highest scoring reg-
ulators as the final list (a cutoff well above assignment of regulators expected by chance), with
Module Network Inference with Lemon-Tree
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92 amplified and 579 deleted selected genes (S1 Text; S2 and S3 Tables). The resulting glioblas-
toma module network is composed of 121 clusters of co-expressed genes, together with associ-
ated prioritized lists of high-scoring SCNA genes (associated to amplified and deleted regions).
More than 60% of the clusters have a significant Gene Ontology (GO) enrichment (cor-
rected p-value< 0.05, Table 2 and S4 Table). Several of those enriched clusters can be related
to the hallmarks of cancers, ten distinctive and complementary capabilities that have been de-
fined as the fundamental biological capabilities acquired during tumor development [37, 38].
For instance, we have 11 clusters enriched for GO categories related to cell cycle processes and
regulation (p-value< 0.05), with three of them having very strong enrichment (corrected p-
values 4×10−18, 6×10−24 and 9×10−71, Table 2). The cell cycle is deregulated in most cancers
and is at the heart of the “sustaining proliferative signaling” hallmark. Eight clusters are en-
riched for categories related to immune response, with two of them displaying strong enrich-
ment (corrected p-values 6×10−33 and 6×10−45, Table 2). Most tumor lesions contain immune
cells present at various degrees of density. Intense recent research has shown that this immune
response is linked to two phenomena. First, it is obviously an attempt by the immune system to
eradicate the tumor, but secondly, there is now a large body of evidence showing that immune
cells also have strong tumor-promoting effects, and both aspects are categorized as part of the
Table 2. GO enrichment for glioblastoma modules.
Group Module number Module nb of genes Corrected p-value GO category
Cell Cycle 1 85 9×10−71 cell cycle phase
2×10−67 cell cycle process
6×10−63 mitotic cell cycle
11 60 6×10−24 cell cycle phase
6×10−24 mitotic cell cycle
33 36 4×10−18 cell cycle phase
1×10−17 mitotic cell cycle
Immune response 3 145 6×10−45 immune response
6×10−45 immune system process
1×10−26 inﬂammatory response
4×10−23 innate immune response
14 127 6×10−33 response to type I interferon
8×10−24 innate immune response
26 54 7×10−6 defense response
9×10−6 immune response
48 37 1×10−6 immune system process
Vasculature 27 40 4×10−16 vasculature development
2×10−15 blood vessel development
7×10−13 angiogenesis
37 81 3×10−10 extracellular matrix organization
9×10−6 blood vessel development
Chromatin modiﬁcations 70 12 9×10−24 chromatin assembly
8×10−24 nucleosome assembly
5×10−17 chromatin organization
Selection of clusters of co-expressed genes from the glioblastoma module network highly enriched for GO categories related to cancer hallmarks.
Enriched categories are grouped into broader functional groups. Only a subset of the GO categories are displayed in this table. The full list is available as
S1 Table.
doi:10.1371/journal.pcbi.1003983.t002
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hallmarks of cancer [38]. For instance, microglia are a type of glial cells that act as macrophages
of the brain and the spinal cord and thus act as the main form of immune response in the cen-
tral nervous system. They constitute the dominant form of glioma tumor infiltrating immune
cells, and they might promote tumor growth by facilitating immunosuppression of the tumor
microenvironment [39]. The development of blood vessels (angiogenesis) is another crucial
hallmark of cancer, providing sustenance in oxygen and nutrients and a way to evacuate meta-
bolic wastes and carbon dioxide [38]. Glioblastoma multiforme is characterized by a striking
and dramatic induction of angiogenesis [31]. There are seven clusters enriched for GO catego-
ries related to angiogenesis and blood vessel development, with two of them having strong en-
richment (corrected p-values 4×10−6 and 9×10−16, Table 2). A recent large-scale integrative
study of hundreds of glioblastoma samples has shown that chromatin modifications could po-
tentially have high biological relevance for this type of tumor [40]. Interestingly, we have a clus-
ter highly enriched in chromatin assembly and organization (corrected p-value 5×10−17 and
9×10−24, Table 2). Taken together, these results show that the clusters of co-expressed genes in
the module network are representative of the molecular functions and biological processes in-
volved in tumor in general and more specifically in glioblastoma.
In the glioblastoma module network, we inferred a list of amplified and deleted SCNA genes
linked to one or more clusters of co-expressed genes. Some of those SCNA genes are highly
connected, representing potential master copy-number regulators for module activity. To iden-
tify and analyze those SCNA hub genes, we calculated for each high-scoring regulator the sum
of the scores obtained in each module, and ranked them by decreasing score for amplified
(Table 3) and deleted (Table 4) genes. Among these genes, we find many well-known onco-
genes and tumor supressors that are frequently amplified, deleted or mutated in glioblastoma.
Those genes include EGFR, PDGFRA, FGFR3, PIK3CA,MDM4, CDKN2A/B, PTEN and are all
members of the core alterated pathways in glioblastoma controlling key phenotypes such as
proliferation, apoptosis and angiogenesis (Fig. 3, [3,35,40,41]). Those genes and pathways are
also frequently impaired in many other types of tumors [42–44]. In addition, we find in those
lists of hub genes a number of interesting new candidates, both in amplified and deleted genes,
that have not been associated with glioblastoma before. To better visualize the importance and
role of both the well-known and novel SCNAs prioritized by Lemon-Tree, we represent those
that are part of the three core pathways altered in glioblastoma as a network with edges repre-
senting activation or inhibition relationships, together with their levels of gene gains and losses
in glioblastoma samples (Fig. 3).
Within the list of amplified gene hubs (Table 3), we find a number of genes that have been
rarely or never associated before with glioblastoma. INSR is a gene encoding for the insulin re-
ceptor, a transmembrane receptor activated by insuline and IGF factors, member of the tyro-
sine receptor kinase family, and playing a key role in glucose homeostasis. INSR is selected as a
high-scoring regulator in 15 modules and ranked in third position in the list of amplified gene
hubs. It is found to be amplified as low-level gain or higher in 39% of the samples (Table 3). Be-
yond its well-known role in glucose homeostasis, INSR stimulates cell proliferation (Fig. 3) and
migration and is often aberrantly expressed in cancer cells [45]. Consequently, amplification of
INSR in glioblastoma may enhance proliferation.MYCN encodes a transcription factor (N-
myc) highly expressed in fetal brain and critical for normal brain development. It is also a well-
known proto-oncogene, and amplification of N-myc is associated with poor outcome in neuro-
blastoma [46].MYCN is amplified as low-level gain or higher in 8% of the glioblastoma sam-
ples and is connected to 21 modules (Table 3).MYCN is part of the RB signaling pathway, and
is also strongly connected to the RTK / PI3K and p53 pathways (Fig. 3), with a direct influence
on proliferation. For that reason, its amplification may also favor proliferation in glioblastoma.
KRIT1 (also known as CCM1) is a gene crucial for maintaining the integrity of the vasculature
Module Network Inference with Lemon-Tree
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and for normal angiogenesis. Loss of function of this gene is responsible for vascular malforma-
tions in the brain known as cerebral cavernous malformations [47, 48]. It is amplified as low-
level gain or higher in 83% of the glioblastoma samples and it is listed in the top 10 hubs in our
list (Table 3). The consequences of KRIT1 amplification are not completely clear, but we may
hypothesize that it is required for proper angiogenesis development, which is a hallmark of
glioblastoma [31], and that it may also help decrease apoptosis (Fig. 3).
In the list of putative deleted genes, PAOX (polyamine oxidase) is ranked first, with a con-
nection to 54 modules and the highest sum of scores value. It is classified as single loss (GISTIC
call value of -1 or lower) in 89% of the samples. This is a very high value, comparable to the
value obtained for the classical tumor suppressor CDKN2A (75%, Table 4). Amine oxidases are
involved in the metabolism of polyamines, regulating their intracellular concentrations and
elimination. The products of this metabolism (e.g. hydrogen peroxyde) are cytotoxic and have
been considered as a cause for apoptotic cell death. Amine oxidases are considered as biological
regulators for cell growth and differentiation, and a primary involvement of amine oxidases in
cancer growth inhibition and progression has been demonstrated [49]. Therefore, PAOX
might have a tumor suppressor activity and its deletion in many glioblastoma samples could
provide a selective advantage to glioblastoma tumor cells. Interestingly, amino acids metabo-
lism is not part of the standard alterated pathways in glioblastoma (explaining why we did not
represent PAOX on Fig. 3), but targeting this pathway could lead to novel therapeutic
Table 3. High-scoring ampliﬁed gene hubs detected by Lemon-Tree.
Symbol Pathway Band Nm Sum score % amp. M-list P-list
CHIC2 4q12 32 5884 19 x x
EGFR EGFR signalling 7p11.2 24 5184 87 x x
INSR EGFR signalling 19p13.2 15 3918 39 x x
ASAP1 Membrane cytoskeleton interactions, cell motility 8q24.21 16 3119 11
MYCN Regulation of transcription 2p24.3 21 3028 8 x
C1orf101 1q44 19 2980 17 x
RHOB Rho protein signal transduction 2p24.1 19 2731 7
KRIT1 Small GTPase mediated signal transduction 7q21.2 11 2242 83
CCNE1 Regulation of cell cycle 19q12 14 1980 36 x x
SDCCAG8 1q43 14 1973 17 x
ADCY8 Intracellular signal transduction 8q24.22 12 1949 11
PDGFRA Cell proliferation, signal transduction 4q12 10 1874 18 x x
DDX1 Regulation of translation 2p24.3 16 1763 8
MDM4 p53 regulation 1q32.1 9 1385 27 x x
mir-4283-2 7q11.21 10 1374 80
PRDM2 Regulation of transcription 1p36.21 8 1323 15
FGFR3 Cell growth 4p16.3 5 1031 8 x x
SCIMP Immune response, signal transduction 17p13.2 8 1022 8
GSDMC Epithelial cell proliferation and apoptosis 8q24.21 8 919 11
COL4A1 Angiogenesis 13q34 2 743 5 x
PIK3CA Cell signalling, cell growth 3q26.3 7 743 17 x
List of the top 20 ampliﬁed genes ordered by decreasing sum of score values. Nm: number of modules in which the gene is selected as a high-scoring
regulator. % amp.: percentage of samples in which the gene is classiﬁed as low-level gain or high-level ampliﬁcation (according to GISTIC putative calls).
M-list: presence in a list of genes frequently mutated in cancer, compiled from [42–44]. P-list: presence in a list of genes recurrently ampliﬁed or deleted in
11 cancer types [33].
doi:10.1371/journal.pcbi.1003983.t003
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treatments [50]. KLLN encodes a nuclear transcription factor and shares a bidirectional pro-
moter with PTEN. It is activated by p53 and is involved in S phase arrest and apoptosis [51].
Recent studies show that KLLN has a tumor supressor effect and is associated with worse prog-
nosis in prostate and breast carcinomas [52, 53]. Consequently, the loss of KLLN that is ob-
served in 88% of the glioblastoma samples (Table 4) would help the development of tumor
cells by decreasing apoptosis and favoring proliferation (Fig. 3).
To assess the biological relevance of the amplified and deleted gene hubs in the module net-
work, we analyzed the prognosis value of the top gene hubs by survival analysis, using the clini-
cal data available for TCGA samples (survival time and status of the patient). We constructed
Kaplan-Meier estimates using GISTIC putative calls to define genes having single or deep copy
loss (i.e. GISTIC call value-1) and genes having low-level gains or high-level amplifications
Table 4. High-scoring deleted genes detected by Lemon-Tree.
Symbol Pathway Band Nb modules Sum score % del. M-list P-list
PAOX Polyamine homeostasis, apoptosis 10q26.3 54 7937 89 x x
CDKN2A Negative regulation of cell proliferation 9p21.3 31 4785 75 x
mir-3201 22q13.32 21 3030 37 x
mir-340 5q35.3 35 3030 10 x
mir-604 10p11.23 49 2930 82 x
mir-938 10p11.23 45 2921 82
C9orf53 9p21.3 29 2897 75 x
ATAD1 10q23.31 55 2433 88
KIAA0125 14q32.33 30 2117 28 x
mir-548q 10p13 35 2017 81
OMG Cell adhesion 17q11.2 21 1697 13 x
EVI2B 17q11.2 19 1629 13 x
KRTAP5-6 11p15.5 18 1564 21
SRGAP1 Cell migration 12q14.2 20 1397 14
KLLN Cell cycle arrest, apoptosis 10q23.31 34 1374 88 x
FLT4 Protein tyrosine kinase signalling 5q35.3 12 1022 10 x
EFCAB4A Metabolic process 11p15.5 33 964 23
HBD 11p15.4 38 964 20
DMRTA2 Regulation of transcription 1p32.3 28 926 5
TBC1D30 12q14.3 15 791 13
ART5 Protein glycosylation 11p15.4 11 785 21
FAM19A5 22q13.32 4 745 37 x
EVI2A 17q11.2 17 709 13 x
ARID2 12q12 5 681 14 x
WDR37 10p15.3 21 614 81
MOB2 Death receptor signalling 11p15.5 15 599 23
PTEN EGFR signalling, AKT pathway 10q23.31 19 593 89 x x
MUC4 Cell matrix adhesion, transport 3q29 10 588 11
IDI1 Isoprenoids synthesis 10p15.13 23 569 81
CSMD1 8p23.2 8 566 12 x
CDKN2B Negative regulation of cell proliferation 9p21.3 19 565 75 x
List of top 30 deleted genes ordered by decreasing sum of score values. % del.: percentage of samples in which the gene is classiﬁed as single-copy loss
or deep loss (according to GISTIC putative calls). Nm, M-list and P-list: see Table 3.
doi:10.1371/journal.pcbi.1003983.t004
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(i.e. GISTIC call value1. The differences between groups were formally tested and a total of 3
amplified genes and 18 deleted genes from the lists displayed in Tables 3 and 4 have significant
p-values< 0.05 (Fig. 4 and S6 Table). Interestingly, among those genes we find the well-known
glioblastoma oncogene EGFR and tumor suppressors CDKN2A and PTEN, but also novel can-
didates such as KRIT1 and PAOX described in the previous paragraph. Glioblastoma patients
having copy-number alterations for those genes have a worse survival prognostic. This indi-
cates the biological relevance of those genes that may be used as biomarkers.
Availability and Future Directions
The Lemon-Tree software is hosted at Google Code (http://lemon-tree.googlecode.com/). The
source code, executables and documentation can be downloaded with no restrictions and no
registration, and are released under the terms of the GNU General Public License (GPL) ver-
sion 2.0. Developers and users can join the project by contacting the authors and there is a
mailing list for discussions and news about module networks and the project. A step-by-step
Fig 3. Glioblastoma signaling pathway alterations for top hub regulators. Copy number alterations for a selection of predicted hub regulators are
indicated for canonical glioblastoma signaling pathways p53, RB and RTK/PI3K. Genes selected by the algorithm are indicated in black boxes, while light
grey boxes depict genes that were not selected by the algorithm but are key factors for the pathway. Purple hexagons indicate phenotypes. Percentage of
copy gain or loss is indicated by value and by color shades of red for gene gains and green for gene losses. The values are taken from GISTIC putative calls
for low-levels gains or single-copy losses on 563 glioblastoma samples (data from the Broad institute).
doi:10.1371/journal.pcbi.1003983.g003
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tutorial to learn how to install and use the software is available on the wiki section, together
with the corresponding data sets.
In the future, we intend to extend Lemon-Tree’s support for explicitly modelling causal relations
between regulator types and to incorporate complementary algorithms available in the literature
for integrating gene-based methods, physical interactions and cross-species data. Firstly, the cur-
rent version of Lemon-Tree is able to associate co-expression modules to multiple ‘regulator’ types
(e.g. expression regulators, structural DNA variants, phenotypic states, etc.) by assigning each of
those independently as regulators of a module. We will extend the software with Bayesian methods
to account for possible causal relations between regulator types, e.g. when the association between
a module and expression regulator can be partly explained by a structural DNA variant. Secondly,
a key long-term objective of the Lemon-Tree project is to provide a general open-source repository
for module network inference tools with a consistent user interface. As a first step, the current ver-
sion of Lemon-Tree implements algorithms previously developed by our group [14–17]. In the fu-
ture, we intend to extend it with complementary algorithms developed by other groups, including
algorithms to combine the strengths of module network methods with gene-based methods [18],
to incorporate physical protein-protein or protein-DNA interactions as a prior in the regulator as-
signment procedure [13] or to infer module networks frommultiple species simultaneously [19]. A
document detailing guidelines to implement new functions in the Lemon-Tree Java codebase is
available on the project wiki.
Supporting Information
S1 Table. Complete list of clusters and genes for the glioblastoma dataset.
(XLS)
Fig 4. Kaplan-Meier survival curves for a selection of top hub glioblastoma genes predicted by the Lemon-Tree algorithm. The top three panels are
genes having low-levels gains or high-level amplifications (magenta) compared to normal (blue), the bottom three panels are genes having single-copy loss
or homozygous deletions (green) compared to normal (blue). All genes display significant differences between the groups (p< 0.05, see S6 Table for a full
list of p-values). Patient with putative gene gains or losses have significantly worse prognosis (lower values on the y-axis). The x-axis on all figures represent
the time in number of days.
doi:10.1371/journal.pcbi.1003983.g004
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